Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom
Authors
Keywords
-
Journal
TRANSFUSION
Volume 56, Issue 5, Pages 1038-1045
Publisher
Wiley
Online
2016-04-04
DOI
10.1111/trf.13513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C in patients with β-thalassemia major. A single-centre experience
- (2013) Christos Triantos et al. ANNALS OF HEMATOLOGY
- Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
- (2013) Rosarin Sruamsiri et al. BMC HEALTH SERVICES RESEARCH
- Combined Chelation Therapy with Deferoxamine and Deferiprone in β-Thalassemia Major: Compliance and Opinions of Young Thalassemic Patients
- (2013) Emmanuel S. Hatzipantelis et al. HEMOGLOBIN
- Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
- (2013) Anthony Bentley et al. PHARMACOECONOMICS
- Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)
- (2013) Elliott Vichinsky et al. TRANSFUSION
- Common Complications in Beta-Thalassemia Patients.
- (2013) Ayhan Yaman UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi
- Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload
- (2012) Jonathan Karnon et al. CLINICAL DRUG INVESTIGATION
- Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study
- (2011) G. Derchi et al. European Journal of Echocardiography
- Catalogue of EQ-5D Scores for the United Kingdom
- (2011) Patrick W. Sullivan et al. MEDICAL DECISION MAKING
- A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
- (2010) Pattara Leelahavarong et al. BMC HEALTH SERVICES RESEARCH
- The influence of treatment in specialized centers on survival of patients with thalassemia major
- (2009) Gian Luca Forni et al. AMERICAN JOURNAL OF HEMATOLOGY
- Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
- (2009) Aurelio Maggio et al. BLOOD CELLS MOLECULES AND DISEASES
- Long-term sequential deferiprone-deferoxamineversusdeferiprone alone for thalassaemia major patients: a randomized clinical trial
- (2009) Aurelio Maggio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results
- (2009) Isabelle Thuret et al. Hematology
- Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload
- (2008) Krista A. Payne et al. ADVANCES IN THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now